ARCHIVES

NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period

This article is from The Cancer Letter archive.

Vol. 11 No. 40 | October 18, 1985

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

In Brief: Margaret Sloan, Pioneer In International Medicine Collaboration, Dies; Hammer To Address AACI

January 1, 1982

NCI’s Independence To Be Challenged By Edwards When Cancer Act Comes Up For Renewal Next Year

December 21, 1973

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

More Bad News For Estrogen: Increased Ovarian Cancer Risk

July 19, 2002

Sentinel Node Disection No Worse Than Axillary

February 25, 2011